IGC Pharma, Inc.
IGC$18M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaPOTOMAC70 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
3
Next Catalyst
Jun 26, 2026
6dMarket Overview
Stock performance and key metrics
IGC News
Catalyst Timeline
3 upcoming, 0 past
EarningsNext
IGC Earnings Report
Jun 26, 2026Confirmed
EPS Est: $-0.02 | FQ end 2026-03
2 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IGC-AD1-Active | Phase 2 | Alzheimer Disease | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply